Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 56% ± 19% | |
peripheral blood | 19 studies | 66% ± 17% | |
intestine | 15 studies | 52% ± 24% | |
kidney | 9 studies | 49% ± 25% | |
eye | 7 studies | 43% ± 18% | |
lymph node | 7 studies | 62% ± 24% | |
uterus | 6 studies | 68% ± 30% | |
pancreas | 5 studies | 50% ± 25% | |
liver | 5 studies | 45% ± 24% | |
placenta | 5 studies | 31% ± 11% | |
bone marrow | 4 studies | 56% ± 24% | |
esophagus | 4 studies | 53% ± 24% | |
prostate | 4 studies | 57% ± 12% | |
skin | 4 studies | 70% ± 14% | |
breast | 4 studies | 80% ± 9% | |
brain | 4 studies | 35% ± 13% | |
ovary | 3 studies | 53% ± 28% | |
heart | 3 studies | 23% ± 4% | |
adrenal gland | 3 studies | 63% ± 21% | |
stomach | 3 studies | 35% ± 10% | |
thymus | 3 studies | 38% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 98% | 32327.39 | 569 / 578 | 97% | 304.83 | 1115 / 1155 |
ovary | 96% | 50787.29 | 173 / 180 | 99% | 519.83 | 425 / 430 |
bladder | 90% | 27667.14 | 19 / 21 | 97% | 457.14 | 490 / 504 |
esophagus | 85% | 20924.68 | 1229 / 1445 | 100% | 389.24 | 183 / 183 |
thymus | 88% | 17145.56 | 577 / 653 | 96% | 462.79 | 581 / 605 |
prostate | 88% | 15974.44 | 215 / 245 | 94% | 552.61 | 474 / 502 |
adrenal gland | 86% | 18507.86 | 222 / 258 | 94% | 578.80 | 216 / 230 |
intestine | 80% | 18390.72 | 775 / 966 | 99% | 370.87 | 522 / 527 |
breast | 88% | 20505.76 | 403 / 459 | 91% | 247.42 | 1015 / 1118 |
stomach | 74% | 20030.51 | 267 / 359 | 98% | 364.52 | 281 / 286 |
skin | 91% | 29634.99 | 1655 / 1809 | 79% | 139.41 | 373 / 472 |
kidney | 81% | 11897.46 | 72 / 89 | 81% | 249.02 | 733 / 901 |
uterus | 53% | 11810.11 | 90 / 170 | 98% | 528.61 | 448 / 459 |
pancreas | 45% | 5468.16 | 149 / 328 | 98% | 493.57 | 174 / 178 |
liver | 71% | 10758.49 | 161 / 226 | 67% | 132.38 | 272 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 265.70 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 577.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 463.56 | 1 / 1 |
blood vessel | 99% | 61188.01 | 1319 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 28885.59 | 898 / 929 | 0% | 0 | 0 / 0 |
brain | 28% | 3002.98 | 730 / 2642 | 67% | 155.54 | 470 / 705 |
adipose | 94% | 38029.57 | 1130 / 1204 | 0% | 0 | 0 / 0 |
spleen | 93% | 12272.46 | 225 / 241 | 0% | 0 | 0 / 0 |
heart | 71% | 15342.53 | 615 / 861 | 0% | 0 | 0 / 0 |
muscle | 44% | 4906.50 | 353 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 19% | 18.70 | 15 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0033687 | Biological process | osteoblast proliferation |
GO_0060136 | Biological process | embryonic process involved in female pregnancy |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0046697 | Biological process | decidualization |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001829 | Biological process | trophectodermal cell differentiation |
GO_0001570 | Biological process | vasculogenesis |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0045597 | Biological process | positive regulation of cell differentiation |
GO_0060716 | Biological process | labyrinthine layer blood vessel development |
GO_0002158 | Biological process | osteoclast proliferation |
GO_2000319 | Biological process | regulation of T-helper 17 cell differentiation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0140467 | Biological process | integrated stress response signaling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0035976 | Cellular component | transcription factor AP-1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | JUNB |
Protein name | Transcription factor JunB (Transcription factor AP-1 subunit JunB) Ribonuclease (EC 3.1.26.4) |
Synonyms | hCG_172481 |
Description | FUNCTION: Transcription factor involved in regulating gene activity following the primary growth factor response. Binds to the DNA sequence 5'-TGA[GC]TCA-3'. Heterodimerizes with proteins of the FOS family to form an AP-1 transcription complex, thereby enhancing its DNA binding activity to an AP-1 consensus sequence and its transcriptional activity (By similarity). . FUNCTION: Catalytic subunit of RNase HII, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging-strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. .; FUNCTION: Endonuclease that specifically degrades the RNA of RNA-DNA hybrids. . |
Accessions | P17275 Q5U079 ENST00000302754.6 Q6IBG3 |